Table 1.
Descriptive statistics of demographic and laboratory parameters (median and IQR).
| Normal range | COVID-19 (n = 22) | Non-COVID-19 (n = 14) | |
|---|---|---|---|
| Age [years]⁎ | 64 (52, 70) | 49 (36, 57) | |
| Male/female | 19/3 | 9/5 | |
| BMI [kg/m2] | 18.5–24.9 | 27 (24, 31) | 26 (22, 32) |
| Horovitz index | 161 (119, 190) | 86 (76, 171) | |
| Haemoglobin [g/dl]⁎⁎ | 13.1 (11.8, 13.3) | 9.3 (8.3, 12.6) | |
| Female | 11.5–15.4 | 11.1 (10.3, 12.4) | 9.3 (8.7, 9.7) |
| Male | 13.5–17.5 | 13.1 (12.0, 13.3) | 10.2 (7.8, 13.7) |
| Haematocrit⁎⁎ | 0.356 (0.334, 0.377) | 0.301 (0.268, 0.326) | |
| Female | 0.346–0.453 | 0.348 (0.290, 0,363) | 0.298 (0.285, 0.304) |
| Male | 0.396–0.506 | 0.361 (0.337, 0.376) | 0.308 (0.257, 0.434) |
| SOFA score⁎ | 11.5 (10.3, 12.0) | 15.0 (13.3, 15.0) | |
| Leukocytes [G/l] | 3.9–10.4 | 11.9 (7.3, 15.3) | 16.0 (9.6, 24.6) |
| Bilirubin [mg/dl] | ≤1.2 | 0.6 (0.4, 0.9) | 0.8 (0.6, 1.1) |
| GOT [U/l] | ≤49 | 54 (42, 74) | 68 (45, 104) |
| GPT [U/l]⁎ | ≤49 | 47 (33, 87) | 31 (25, 36) |
| GGT [U/l] | ≤59 | 86 (35, 149) | 90 (38, 131) |
| Lactate [mmol/l]⁎ | ≤2.4 | 1.1 (1.0, 1.4) | 2.1 (1.1, 7.1) |
| Creatinine [mg/dl]⁎ | 0.5–1.2 | 1.1 (0.9, 1.4) | 1.4 (1.1, 2.6) |
| Urea [mg/dl]⁎ | 17–49 | 30 (23, 58) | 58 (44, 74) |
| CRP [mg/dl]⁎ | ≤0.5 | 15.6 (10.3, 18.8) | 27.4 (16.0, 32.8) |
| PCT [ng/dl]⁎ | ≤0.1 | 0.4 (0.1, 0.9) | 3.5 (1.0, 86.9) |
| IL-6 [pg/ml]⁎ | ≤5.9 | 147 (70, 431) | 2710 (271, 45202) |
BMI body mass index, SOFA score sequential organ failure assessment score, GOT glutamate-oxaloacetate-transaminase, GPT glutamate-pyruvate-transaminase, GGT gamma-glutamyl-transferase, CRP C-reactive protein, PCT procalcitonin.
⁎
p < 0.05.
⁎⁎
No differences between genders.